Comparative gene expression of intestinal metabolizing enzymes

Biopharmaceutics and Drug Disposition

Volumn 30, Issue 8, 2009, Pages 411-421

  Shin, Ho Chul ^a   Kim, Hye Ryoung ^a   Cho, Hee Jung ^a   Yi, Hee ^a   Cho, Soo Min ^a   Lee, Dong Goo ^a   Abd El Aty, A M ^a   Kim, Jin Suk ^a   Sun, Duxin ^b   Amidon, Gordon L ^b  

^a Konkuk University   (South Korea)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Gene expression; Intestine; Metabolizing enzymes; Mouse rat human

Indexed keywords

CHOLESTANETRIOL 26 MONOOXYGENASE; CYTOCHROME P450 11B1; CYTOCHROME P450 17A1; CYTOCHROME P450 2B19; CYTOCHROME P450 2B20; CYTOCHROME P450 2B6; CYTOCHROME P450 2C18; CYTOCHROME P450 2C65; CYTOCHROME P450 2C9; CYTOCHROME P450 2D18; CYTOCHROME P450 2D26; CYTOCHROME P450 2D6; CYTOCHROME P450 3A25; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; CYTOCHROME P450 3A9; CYTOCHROME P450 4F1; CYTOCHROME P450 4F14; CYTOCHROME P450 4F3; CYTOCHROME P450 4F6; CYTOCHROME P450 4V3; DRUG METABOLIZING ENZYME; GLUCURONOSYLTRANSFERASE 1A6; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; INTESTINE ENZYME; MESSENGER RNA; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; HUMAN VERSUS NONHUMAN DATA; INTESTINE ABSORPTION; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PROTEIN EXPRESSION; RAT; RNA ISOLATION; SPECIES COMPARISON; SPECIES DIFFERENCE;

ANIMALS; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCURONOSYLTRANSFERASE; HUMANS; INTESTINES; MICE; MICROSOMES, LIVER; PHARMACEUTICAL PREPARATIONS; RATS;

EID: 70549107984     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.675     Document Type: Article

References (40)

1. Norinder U. In silico modelling of ADMET - a minireview of work from 2000 to 2004. SAR QSAR Environ Res 2005; 16: 1-11.
2. van deWaterbeemd H, Gifford E. ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2003; 2: 192-204.
3. Clark DE, Grootenhuis PD. Progress in computational methods for the prediction of ADMET properties. Curr Opin Drug Discov Devel 2002; 5: 382-390. (Pubitemid 36285643)
4. Fiegler H, Carter NP. Genomic array technology. Methods Cell Biol 2004; 75: 769-785.
5. Anderle P, Huang Y, Sadee W. Intestinal membrane transport of drugs and nutrients: genomics of membrane transporters using expression microarrays. Eur J Pharm Sci 2004; 21: 17-24. (Pubitemid 38050201)
6. Fang H, Tong W, Perkins R, et al. Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling. BMC Bioinformatics 2005; 6(Suppl 2): S6. (Pubitemid 41574321)
7. Landowski CP, Sun D, Foster DR, et al. Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters. J Pharmacol Exp Ther 2003; 306: 778-786. (Pubitemid 36886180)
8. Takara K, Ohnishi N, Horibe S, Yokoyama T. Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAS in small intestine. Drug Metab Dispos 2003; 31: 1235-1239. (Pubitemid 37152974)
9. Rushmore TH, Kong AN. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr Drug Metab 2002; 3: 481-490. (Pubitemid 34987481)
10. Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y. Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 2003; 55: 425-461. (Pubitemid 37013212)
11. Beaumont K. The importance of gut wall metabolism in determining drug bioavailability. In Drug Bioavailability/Estimation of Solubility, Permeability and Absorption. Volume 18, Methods and Principles in Medicinal Chemistry, Waterbeemd HV-d, Lennernas H, Artursson P (eds).Weinheim: Wiley-VCH, 2003; 311-328.
12. Tsuji A. Transporter-mediated drug interactions. Drug Metab Pharmacokinet 2002; 17: 253-274.
13. Cao X, Gibbs ST, Fang L, et al. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res 2006; 23: 1675-1686. (Pubitemid 44200529)
14. Bu HZ. A literature review of enzyme kinetic parameters for CYP3A4-mediated metabolic reactions of 113 drugs in human liver microsomes: structure-kinetics relationship assessment. Curr Drug Metab 2006; 7: 231-249.
15. Berecz R, Dorado P, De La Rubia A, et al. The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions. Curr Drug Targets 2004; 5: 573-579. (Pubitemid 39004432)
16. Sun D, Lennernas H, Welage LS, et al. Comparison of human duodenum and Caco-2 gene expression profiles for 12000 gene sequences tags and correlation with permeability of 26 drugs. Pharm Res 2002; 19: 1400-1416. (Pubitemid 35266543)
17. Spatzenegger M, Jaeger W. Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metab Rev 1995; 27: 397-417.
18. Watkins PB. Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterol Clin North Am 1992; 21: 511-526.
19. Fujita K. Cytochrome P450 and anticancer drugs. Curr Drug Metab 2006; 7: 23-37.
20. Kaminsky LS, Fasco MJ. Small intestinal cytochromes P450. Crit Rev Toxicol 1991; 21: 407-422.
21. Anzenbacher P, Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 2001; 58: 737-747.
22. Michalets EL. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy 1998; 18: 84-112. (Pubitemid 28059007)
23. Sitkiewicz D. Mechanisms of drug metabolism - implications for drug interaction. Pol Merkuriusz Lek 2000; 9: 595-597.
24. Martignoni M, Groothuis G, de Kanter R. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine. Drug Metab Dispos 2006; 34: 1047-1054. (Pubitemid 43763764)
25. Zhang QY, Dunbar D, Kaminsky LS. Characterization of mouse small intestinal cytochrome P450 expression. Drug Metab Dispos 2003; 31: 1346-1351. (Pubitemid 37310323)
26. Kato M. Intestinal first-pass metabolism of CYP3A4 substrates. Drug Metab Pharmacokinet 2008; 23: 87-94.
27. Shayeganpour A, El-Kadi AO, Brocks DR. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms. Drug Metab Dispos 2006; 34: 43-50. (Pubitemid 43042645)
28. Wacher VJ, Silverman JA, Zhang Y, Benet LZ. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. J Pharm Sci 1998; 87: 1322-1330. (Pubitemid 28514135)
29. Zierold C, Mings JA, Deluca HF. 19nor-1,25-Dihydroxyvitamin D2 specifically induces CYP3A9 in rat intestine more strongly than 1,25-dihydroxyvitamin D3 in vivo and in vitro. Mol Pharmacol 2006; 69: 1740-1747.
30. Xue L, Zgoda VG, Arison B, Almira Correia M. Structure-function relationships of rat liver CYP3A9 to its human liver orthologs: site-directed active site mutagenesis to a progesterone dihydroxylase. Arch Biochem Biophys 2003; 409: 113-126. (Pubitemid 36042907)
31. Salinas AE, Wong MG. Glutathione S-transferases - a review. Curr Med Chem 1999; 6: 279-309.
32. Whalen R, Boyer TD. Human glutathione S-transferases. Semin Liver Dis 1998; 18: 345-358.
33. Chasseaud LF. The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv Cancer Res 1979; 29: 175-274.
34. Rath VL, Verdugo D, Hemmerich S. Sulfotransferase structural biology and inhibitor discovery. Drug Discov Today 2004; 9: 1003-1011. (Pubitemid 39574556)
35. Caldwell J. Conjugation reactions in foreign-compound metabolism: definition, consequences, and species variations. Drug Metab Rev 1982; 13: 745-777. (Pubitemid 13242525)
36. Cox B, Kislinger T, Emili A. Integrating gene and protein expression data: pattern analysis and profile mining. Methods 2005; 35: 303-314. (Pubitemid 40255595)
37. Greenbaum D, Jansen R, Gerstein M. Analysis of mRNA expression and protein abundance data: an approach for the comparison of the enrichment of features in the cellular population of proteins and transcripts. Bioinformatics 2002; 18: 585-596. (Pubitemid 34525064)
38. Terada T, Inui K. Gene expression and regulation of drug transporters in the intestine and kidney. Biochem Pharmacol 2007; 73: 440-449. (Pubitemid 44958370)
39. Berggren S, Gall C, Wollnitz N, et al. Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine. Mol Pharm 2007; 4: 252-257. (Pubitemid 46640601)
40. Kern W, Kohlmann A, Wuchter C, et al. Correlation of protein expression and gene expression in acute leukemia. Cytometry B Clin Cytom 2003; 55: 29-36. (Pubitemid 38295406)